Efficacy and safety in unresectable hepatocellular carcinoma using atezolizumab plus bevacizumab in later-line: A retrospective analysis of real-world evidence.

被引：0
|
作者：
Cheng, Jiamin
Chen, Bowen
Zhang, Xinfeng
Su, Guodong
Peng, Caiyun
Zhou, Lin
Lei, Jin
Li, Yinyin
Lu, Yinying
机构：
[1] Peoples Liberat Army Gen Hosp, Med Ctr 5, Senior Dept Hepatol, Beijing, Peoples R China
[2] Peking Univ, Clin Med Sch 302, Beijing, Peoples R China
[3] Anhui Med Univ, Sch Clin Med 5, Hefei, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16173
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety in advanced hepatocellular carcinoma using atezolizumab plus bevacizumab combined with interventional therapy: A retrospective analysis of real-world evidence.
    Cheng, Jiamin
    Chen, Bowen
    Jing, Yi
    Lu, Yinying
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16112 - E16112
  • [2] Effectiveness and safety of atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: A multicenter, retrospective real-world study in China
    Zhang, Hui
    Shao, Minghua
    Tan, Binbin
    Fu, Yin
    Yuan
    Chen, Hailei
    CANCER RESEARCH, 2024, 84 (06)
  • [3] Initial Experience With Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma: A Real-world Retrospective Study
    Takeda, Soichi
    Namisaki, Tadashi
    Tsuji, Yuki
    Fujimoto, Yuki
    Murata, Koji
    Enomoto, Masahide
    Fujinaga, Yukihisa
    Nishimura, Norihisa
    Kitagawa, Koh
    Takaya, Hiroaki
    Kaji, Kosuke
    Inoue, Takashi
    Kawaratani, Hideto
    Akahane, Takemi
    Mitoro, Akira
    Yoshiji, Hitoshi
    ANTICANCER RESEARCH, 2022, 42 (11) : 5465 - 5473
  • [4] Efficacy and safety in unresectable hepatocellular carcinoma with VP4 tumor embolus using sinilimab plus bevacizumab: A retrospective analysis of real-world evidence
    Cheng, Jiamin
    Chen, Bowen
    Zhang, Xinfeng
    Su, Guodong
    Peng, Caiyun
    Lei, Jin
    Yu, Lingxiang
    Li, Yinyin
    Lu, Yinying
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Efficacy of Atezolizumab Plus Bevacizumab Combined with Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Real-World Study
    Shen, Xiao
    Zhang, Jin-Xing
    Liu, Jin
    Liu, Sheng
    Shi, Hai-Bin
    Cheng, Yuan
    Zhang, Qing-Qiao
    Yin, Guo-Wen
    Zu, Qing-Quan
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 : 1993 - 2003
  • [6] The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey
    Akyildiz, Arif
    Guven, Deniz Can
    Ozluk, Ahmet Anil
    Ismayilov, Rashad
    Mutlu, Emel
    Unal, Olcun Umit
    Yildiz, Ibrahim
    Iriagac, Yakup
    Turhal, Serdar
    Akbas, Sinem
    Bayram, Ertugrul
    Telli, Tugba Akin
    Turkoz, Fatma Paksoy
    Ozcelik, Melike
    Erciyestepe, Mert
    Selvi, Oguzhan
    Gulbagci, Burcu
    Erturk, Ismail
    Isleyen, Zehra Sucuoglu
    Kahraman, Seda
    Akdag, Mutianur Ozkorkmaz
    Hamitoglu, Buket
    Unek, Ilkay Tugba
    Unal, Caglar
    Hacibekiroglu, Ilhan
    Arslan, Cagatay
    Azizy, Abdulmunir
    Helvaci, Kaan
    Demirci, Umut
    Dizdar, Omer
    Basaran, Mert
    Goker, Erdem
    Sendur, Mehmet Ali
    Yalcin, Suayib
    MEDICINE, 2023, 102 (45) : E35950
  • [7] Efficacy and safety of regorafenib combined with PD-1 inhibitors in patients with advanced hepatocellular beyond atezolizumab plus bevacizumab: A retrospective analysis of real-world evidence.
    Zhang, Xinfeng
    Cheng, Jiamin
    Chen, Bowen
    Zhang, Tianlan
    Li, Yinyin
    Zhang, Linzhi
    Dong, Jinghui
    Lu, Yinying
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] THE EFFICACY AND SAFETY OF ATEZOLIZUMAB & BEVACIZUMAB IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA: THE REAL WORLD DATA
    Yoo, Sung Hwan
    Lee, Hyun Woong
    Lee, Jung Il
    HEPATOLOGY, 2023, 78 : S1898 - S1899
  • [9] Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World Practice
    Ando, Yuwa
    Kawaoka, Tomokazu
    Kosaka, Masanari
    Shirane, Yuki
    Johira, Yusuke
    Miura, Ryoichi
    Murakami, Serami
    Yano, Shigeki
    Amioka, Kei
    Naruto, Kensuke
    Kosaka, Yumi
    Uchikawa, Shinsuke
    Kodama, Kenichiro
    Fujino, Hatsue
    Nakahara, Takashi
    Ono, Atsushi
    Murakami, Eisuke
    Yamauchi, Masami
    Okamoto, Wataru
    Takahashi, Shoichi
    Imamura, Michio
    Chayama, Kazuaki
    Aikata, Hiroshi
    CANCERS, 2021, 13 (16)
  • [10] Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: Results from a German real-world cohort
    Jost-Brinkmann, Fabian
    Demir, Muenevver
    Wree, Alexander
    Luedde, Tom
    Loosen, Sven H.
    Mueller, Tobias
    Tacke, Frank
    Roderburg, Christoph
    Mohr, Raphael
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (11) : 1313 - 1325
12345